Page last updated: 2024-09-02

schizandrin b and Triple Negative Breast Neoplasms

schizandrin b has been researched along with Triple Negative Breast Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Dai, X; Guo, G; Liang, G; Qian, J; Wang, O; Yin, C; Zhang, X; Zhang, Y; Zhao, C	1

Other Studies

1 other study(ies) available for schizandrin b and Triple Negative Breast Neoplasms

Article	Year
Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3. Toxicology and applied pharmacology, 2018, 11-01, Volume: 358 Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclooctanes; Dose-Response Relationship, Drug; Female; Humans; Lignans; Mice; Mice, Inbred BALB C; Mice, Nude; Polycyclic Compounds; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays	2018

Article

Year

Schisandrin B exhibits potent anticancer activity in triple negative breast cancer by inhibiting STAT3.

Toxicology and applied pharmacology, 2018, 11-01, Volume: 358

Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Cyclooctanes; Dose-Response Relationship, Drug; Female; Humans; Lignans; Mice; Mice, Inbred BALB C; Mice, Nude; Polycyclic Compounds; STAT3 Transcription Factor; Triple Negative Breast Neoplasms; Tumor Burden; Xenograft Model Antitumor Assays

2018